Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung Maeng, Jay A. Berzofsky, Wei‐Zen Wei et al.|Frontiers in Oncology|2021Cited by 26
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patientsAaron Boothby, Sandhya R. Panch, Matthew Tanner et al.|Blood Advances|2024Cited by 9
Expanding the Role of SH2B3: T Cell Large Granular Lymphocytosis (LGL) and Common Variable Immune Deficiency in the Setting of Biallelic SH2B3 MutationsTiffany Hangse, Eric J. Allenspach, Shalini Pullarkat et al.|Blood|2024Cited by 2